Abstract
Since the discovery of cisplatin, the search for diagnostic or therapeutic agents based on other metals, has expanded intensively owing to the numerous possibilities offered by coordination chemistry. This mini-review focuses on recent advances in the search for RuII polyazaaromatic complexes of potential interest as molecular tools applied to cellular diagnostics or as specific cellular photo-reagents for future biomedical applications. The interaction of RuII polyazaaromatic complexes with living cells is reported, as well as the photo-reaction mechanisms of photo-oxidizing RuII complexes with nucleic acids. The novel strategies currently developed to improve their reactivity and specificity towards DNA, more particularly in the gene-silencing framework, are also discussed.
Keywords: Diagnostic agent, DNA, oligonucleotide, photo-therapeutic agent, ruthenium, living cells, specific cellular photo-reagents, photo-oxidizing RuII complexes, nucleic acids, luminescent probes, luminophores for biomolecules, hydrophobic complexes, emission wavelengths, cell-viability, gel electrophoresis analyses
Current Topics in Medicinal Chemistry
Title: What Does the Future Hold for Photo-Oxidizing RuII Complexes with Polyazaaromatic Ligands in Medicinal Chemistry?
Volume: 12 Issue: 3
Author(s): Jonathan Ghesquiere, Stephane Le Gac, Lionel Marcelis, Cecile Moucheron and Andree Kirsch - De Mesmaeker
Affiliation:
Keywords: Diagnostic agent, DNA, oligonucleotide, photo-therapeutic agent, ruthenium, living cells, specific cellular photo-reagents, photo-oxidizing RuII complexes, nucleic acids, luminescent probes, luminophores for biomolecules, hydrophobic complexes, emission wavelengths, cell-viability, gel electrophoresis analyses
Abstract: Since the discovery of cisplatin, the search for diagnostic or therapeutic agents based on other metals, has expanded intensively owing to the numerous possibilities offered by coordination chemistry. This mini-review focuses on recent advances in the search for RuII polyazaaromatic complexes of potential interest as molecular tools applied to cellular diagnostics or as specific cellular photo-reagents for future biomedical applications. The interaction of RuII polyazaaromatic complexes with living cells is reported, as well as the photo-reaction mechanisms of photo-oxidizing RuII complexes with nucleic acids. The novel strategies currently developed to improve their reactivity and specificity towards DNA, more particularly in the gene-silencing framework, are also discussed.
Export Options
About this article
Cite this article as:
Ghesquiere Jonathan, Le Gac Stephane, Marcelis Lionel, Moucheron Cecile and Kirsch - De Mesmaeker Andree, What Does the Future Hold for Photo-Oxidizing RuII Complexes with Polyazaaromatic Ligands in Medicinal Chemistry?, Current Topics in Medicinal Chemistry 2012; 12 (3) . https://dx.doi.org/10.2174/156802612799079008
DOI https://dx.doi.org/10.2174/156802612799079008 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Agents Targeting Ras Signaling Pathway
Current Pharmaceutical Design Beneficial Effects and Therapeutic Promises of Diterpenes on Respiratory System
Current Respiratory Medicine Reviews PEGylated Lipid Nanocapsules with Improved Drug Encapsulation and Controlled Release Properties
Current Topics in Medicinal Chemistry Unfolding Cardiac Amyloidosis –From Pathophysiology to Cure
Current Medicinal Chemistry Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer
Current Medicinal Chemistry Influence of Usnic Acid and its Derivatives on the Activity of Mammalian Poly(ADP-ribose)polymerase 1 and DNA Polymerase β
Medicinal Chemistry Fecal DNA Genotyping: A Non-invasive Approach to Characterize Mouse Models for Nutrigenomics Cancer Chemoprevention Studies
Current Pharmacogenomics and Personalized Medicine Molecular Surgery with Auger Electron-Emitting Radiopharmaceuticals
Current Radiopharmaceuticals 3D-QSAR and Docking Studies on 2-acyliminobenzimidazoles Derivatives as Potent ALK Inhibitors
Letters in Drug Design & Discovery Medications not Intended for Treatment of Dyslipidemias and with a Variable Effect on Lipids
Current Pharmaceutical Design Design and Development of Drugs Targeting Protein-Protein Interactions – Part-I
Current Topics in Medicinal Chemistry Therapeutically Targeting MicroRNAs in Liver Cancer
Current Pharmaceutical Design Biomarkers of Oxidative Stress and the Relationship to Cigarette Smoking
Mini-Reviews in Organic Chemistry Radiochemotherapy for Non Small Cell Lung Cancer
Current Drug Therapy Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Current Pharmaceutical Design Metallothioneins and Platinum(II) Anti-Tumor Compounds
Current Medicinal Chemistry Patented Herbal Formulations and their Therapeutic Applications
Recent Patents on Drug Delivery & Formulation Editorial (Thematic Issue: Gene Transfer by Electric Fields)
Current Gene Therapy New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer
Current Pharmaceutical Design Pathway-based Approaches to Pharmacogenomics
Current Pharmacogenomics